Sol Capital Management CO Amgen Inc Transaction History

Sol Capital Management CO

  • $901 Million
  • Q3 2024

A detailed history of Sol Capital Management CO transactions in Amgen Inc stock. As of the latest transaction made, Sol Capital Management CO holds 2,107 shares of AMGN stock, worth $557,280. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,107
Previous 2,107 -0.0%
Holding current value
$557,280
Previous $658,000 3.19%
% of portfolio
0.08%
Previous 0.08%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 12, 2022
SELL
$224.46 - $253.15 $4,489 - $5,063
-20 Reduced 0.94%
2,107 $475,000
Q2 2021

Jul 20, 2021
SELL
$233.58 - $259.14 $23,358 - $25,914
-100 Reduced 4.49%
2,127 $518,000
Q3 2020

Oct 23, 2020
SELL
$234.65 - $260.95 $703 - $782
-3 Reduced 0.13%
2,227 $566,000
Q4 2019

Jan 27, 2020
SELL
$189.21 - $243.2 $37,842 - $48,640
-200 Reduced 8.23%
2,230 $538,000
Q2 2019

Jul 17, 2019
SELL
$166.7 - $195.41 $14,669 - $17,196
-88 Reduced 3.49%
2,430 $448,000
Q4 2018

Jan 25, 2019
SELL
$178.4 - $208.25 $8,920 - $10,412
-50 Reduced 1.95%
2,518 $490,000
Q1 2018

Apr 25, 2018
BUY
$169.43 - $198.0 $14,909 - $17,424
88 Added 3.55%
2,568 $438,000
Q4 2017

Jan 31, 2018
SELL
$168.79 - $188.59 $89,458 - $99,952
-530 Reduced 17.61%
2,480 $431,000
Q3 2017

Oct 27, 2017
BUY
$167.29 - $191.0 $503,542 - $574,910
3,010
3,010 $561,000

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sol Capital Management CO Portfolio

Follow Sol Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sol Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Sol Capital Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email